FDA Inspection 1222752 — Q-Pharm Inc.

Q-Pharm Inc. — FEI 3024655174

The FDA completed an inspection of Q-Pharm Inc. on November 15, 2023 in Cambridge. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 4 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 15, 2023
Fiscal Year
2024
Product Type
Veterinary
Project Area
Pre-Approval Eval. of Animal Drugs and Food Additives
Location
Cambridge (Canada)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location
136121 CFR 211.100(a)Absence of Written Procedures
440221 CFR 211.192Written record of investigation incomplete